Sunday, 4 October 2026European Markets

SPBK1 HELGELAND, SPBK1 ØSTFOLD AKE, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - spbk1 helgeland (helg.ol) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
spbk1 helgeland (helg.ol) kr139.00 7.38% 11.4%
spbk1 østfold ake (soag.ol) kr332.00 5.6% 12.61%
wendel (mf.pa) €83.60 4.66% 12.77%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. spbk1 helgeland (helg.ol)

7.38% forward dividend yield and 11.4% return on equity

sparebank 1 helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in norway. the company operates in two segments, retail market and corporate market. it offers savings, investment, and insurance products, as well as leasing and mortgage services. the company is also involved in owning, managing, and letting commercial properties. it operates through branches located in mosjøen, brønnøysund, and sandnessjøen. the company was founded in 1860 and is headquartered in mo i rana, norway.

earnings per share

as for profitability, spbk1 helgeland has a trailing twelve months eps of kr16.

pe ratio

spbk1 helgeland has a trailing twelve months price to earnings ratio of 8.69. meaning, the purchaser of the share is investing kr8.69 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.4%.

moving average

spbk1 helgeland's value is way higher than its 50-day moving average of kr125.00 and way above its 200-day moving average of kr124.09.

more news about spbk1 helgeland.

2. spbk1 østfold ake (soag.ol)

5.6% forward dividend yield and 12.61% return on equity

sparebank 1 østfold akershus, a savings bank, provides various banking products and services. the company offers savings, operating, tax deduction, deposit, placement, and currency accounts; and savings and investment products. it also provides consumer, construction, repayment, boat, motorcycle, and car loans; operating credit products; bank guarantees; operating credit for agriculture; mortgage products; leasing and factoring services. in addition, the company offers various insurance products, such as vehicle, house and travel, personal, animal, liability, work machine, interruption, condominium, cyber, movable property, commercial building, project, transport, crime, bus, group life, health, leisure accident, occupational injury, accident insurance children, and sick pay insurance products; and pension products. further, it provides credit, municipal payment, and other bank cards; payment terminal, debt collection, and document collection services; bonds, forwards, and currency options; invoice automatic, egiro/cremul, kid invoice, and ocr and egiro payment services; and mobile and online banking services. sparebank 1 østfold akershus was founded in 1835 and is headquartered in moss, norway.

earnings per share

as for profitability, spbk1 østfold ake has a trailing twelve months eps of kr40.77.

pe ratio

spbk1 østfold ake has a trailing twelve months price to earnings ratio of 8.14. meaning, the purchaser of the share is investing kr8.14 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.61%.

more news about spbk1 østfold ake.

3. wendel (mf.pa)

4.66% forward dividend yield and 12.77% return on equity

wendel is a private equity firm specializing in equity financing in middle markets and later stages through leveraged buy-out and transactions and acquisitions. it invests in both listed and non-listed companies. the firm typically invests in technology services and software, business services, healthcare and industrial technology. the firm seeks to invest in africa, europe, european developed markets, western europe, particularly france, and north america (united states and canada). it invests between €150 million ($175.46 million) and €500 million ($584.87 million) in companies. it targets majority/control/large minority investments in listed or unlisted companies. the firm seeks to take a seat on the board of directors or supervisory board and key committees of its portfolio companies. it makes balance sheet investments. wendel was founded in 1704 and is headquartered in paris, france with additional offices across asia, north america, united kingdom and europe.

earnings per share

as for profitability, wendel has a trailing twelve months eps of €5.61.

pe ratio

wendel has a trailing twelve months price to earnings ratio of 14.9. meaning, the purchaser of the share is investing €14.9 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.77%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on jun 19, 2023, the estimated forward annual dividend rate is 3.2 and the estimated forward annual dividend yield is 4.66%.

more news about wendel.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com